Feedback / Questions
cetrelimab (JNJ-63723283) - J&J
tolododekin alfa (ANK-101) - Ankyra Therap
http://clinicaltrials.gov/ct2/show/NCT07027514
Jun 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next